Clinical Trial Update: A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps

View source ↗

Summary

A safety study of Remsima SC for rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and psoriasis remains active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• Remsima SC (infliximab)

Snippet

Sponsor: Celltrion | Conditions: Rheumatoid Arthritis, Ankylosing Spondylitis | Status: ACTIVE_NOT_RECRUITING